EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 3-Nov-2026 21:16 ET (4-Nov-2026 02:16 GMT/UTC)

Tumor cells: Disorder can promote spread

Institute of Science and Technology Austria
Peer-Reviewed Publication

In 2024, malignant tumors caused more than 21,300 deaths in Austria, 4.7% more than in 2014. Faced with a similarly pressing global challenge, scientists are striving to better understand what drives cancer cells to grow, spread, and invade healthy tissue. In Science Advances, a team at the Institute of Science and Technology Austria (ISTA) now offers new clues: Using a simplified model, the researchers show how a chaotic environment around tumor cells can promote their invasive behavior. This theoretical concept will need to be examined further in real tumor tissue.

Journal: Science Advances
Funder: European Research Council, Austrian Academy of Sciences

New MRI agent detects lung cancer, hidden metastases earlier than current scans

Georgia State University
Peer-Reviewed Publication

ATLANTA — A multi-institutional research team led by Georgia State University Regents’ Professor Emerita of Biochemistry and Biophysical Chemistry Jenny J. Yang has developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches. Results of this research, recently published in the journal Science Advances, report a precision MRI method that can identify tumors and metastases as small as 1 millimeter.

Journal: Science Advances

VCU Massey Comprehensive Cancer Center researchers receive $2.5M NIH grant to inform breast, pancreatic cancer care

Virginia Commonwealth University
Grant and Award Announcement

Researchers at VCU Massey Comprehensive Cancer Center were recently awarded a $2.5 million R01 grant from the National Cancer Institute. The five-year grant will allow Massey to evaluate the efficacy of TROP2 targeted antibody-drug conjugates (ADCs) to further enhance therapeutic benefits in both breast and pancreatic cancer care.

Massey researchers, led by principal investigator Chuck Harrell, Ph.D., member of the Cancer Biology research program at Massey and professor in the Department of Pathology at the VCU School of Medicine, will look to define what enables responses and resistance to ADCs in order to identify predictive biomarkers and establish therapeutic strategies to optimize TROP2-targeted ADC efficacy in both triple-negative breast cancer (TNBC) and pancreatic ductal adenocarcinoma (PDAC).

Pancreatic cancer uses blood-clotting system to evade immune attack; targeting may improve immunotherapy

The Mount Sinai Hospital / Mount Sinai School of Medicine
Peer-Reviewed Publication

Researchers at the Icahn School of Medicine at Mount Sinai have found that small populations of pancreatic cancer cells can create localized immune-protective niches that shield tumors from immune attack. The finding could open new avenues for making immunotherapy more effective against one of the deadliest forms of cancer.

Journal: Nature

New comprehensive review unlocks the future of layered double hydroxides in biomedicine

Higher Education Press
Peer-Reviewed Publication

A groundbreaking new review article, titled “Recent advances in precise synthesis, functional modification and multidisease theranostic applications of layered double hydroxide nanomaterials,” offers a definitive roadmap for the next generation of smart nanomedicine. Published in Frontiers of Materials Science, this comprehensive study synthesizes decades of research to highlight the transformative potential of layered double hydroxides (LDHs) in treating complex diseases ranging from cancer to neurodegenerative disorders.

Journal: Frontiers of Materials Science

Restoring MHC-I expression could strengthen immune responses against CNS cancers

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – September 9, 2026 – A new review was published in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.”

Journal: Oncotarget

Most patients with appendix cancer may avoid chemotherapy after surgery, study suggests

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Most patients with localized appendix cancer may be able to safely avoid chemotherapy after surgery, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.

Journal: JAMA Surgery

Triple-negative breast cancer: Methylglyoxal at the heart of immune evasion

University of Liège
Peer-Reviewed Publication

The metabolism of cancer cells may play a key role in their ability to evade the immune system. This is demonstrated by a new study conducted by researchers at the University of Liège, which reveals how methylglyoxal stress – a by-product of tumour metabolism – promotes immunosuppression and the formation of metastases, and may contribute to resistance to immunotherapy and the progression of triple-negative cancer.

Journal: Journal for ImmunoTherapy of Cancer

Using AI to design better cancer therapies

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

How researchers at Memorial Sloan Kettering Cancer Center (MSK) are using artificial intelligence (AI) to design better "binders" for CAR T cell therapies.

Journal: Nature Biomedical Engineering

Researchers identify genetic clues that could reveal aggressive prostate cancer

University of Copenhagen
Peer-Reviewed Publication

An international team of researchers led by scientists from the University of Copenhagen and Rigshospitalet has mapped eight genetic ‘fingerprints’ that may explain why some men develop aggressive prostate cancer while others do not. The findings could eventually lead to more personalised treatment.

Journal: Nature

62
63
64
65
66